C18E10: PCR and the Future

C12E18: Other Antimicrobials

Chapter 12, Episode 18 This episode concludes antimicrobial therapy by exploring antibiotic resistance and treatments for non-bacterial pathogens. It explains how bacteria develop resistance through mutation and gene transfer, and why this is a growing public health concern highlighted in the CDC Threat Report. The episode then reviews key drug classes used to treat fungal, protozoan, helminthic, and viral infections, emphasizing their mechanisms of action, clinical uses, and limitations. The overall focus is on understanding how antimicrobial effectiveness depends on targeting the organism while minimizing harm to the host.

C12E17: Antibacterials Part 2

Chapter 12, Episode 17 This episode continues the overview of antibacterial drug classes. It covers drugs that target the cell membrane, then moves into drugs that target DNA and RNA, including, highlighting their bactericidal action and important side effects. The episode also introduces sulfonamides, which inhibit folic acid synthesis and are often used in combination therapies like Bactrim. Finally, it discusses biofilms and how they significantly increase resistance, reinforcing that successful treatment depends on understanding drug targets, bacterial structure, and limitations.

C12E16: Antibacterials Part 1

Chapter 12, Episode 16 This episode begins the discussion of specific antimicrobial drug classes, organized by mechanism of action. It starts with the historical development of Salvarsan and penicillin, then focuses on beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, which inhibit cell wall synthesis and are bactericidal. It also introduces resistance mechanisms like beta-lactamase and combination drugs like Augmentin. The episode then transitions to protein synthesis inhibitors, including tetracyclines, aminoglycosides, and macrolides, highlighting their targets, clinical uses, and key differences such as bacteriostatic vs. bactericidal effects.

C18E10: PCR and the Future

Chapter 18, Episode 10 We finish Chapter 18 by exploring PCR, DNA sequencing, and other molecular technologies, and how they have transformed microbial identification and are shaping the future of diagnostic microbiology.

C18E9: ELISA and Rapid Testing

Chapter 18, Episode 9 Discover how immunologic tests such as ELISA and rapid antigen tests detect pathogens and antibodies, providing faster diagnostic information for patient care.